1
/
of
1
Elabscience
SKU:PKSH033995
Recombinant Human Receptor Tyrosine-Protein Kinase ErbB-3/HER3 (C-Fc)
Recombinant Human Receptor Tyrosine-Protein Kinase ErbB-3/HER3 (C-Fc)
Regular price
$200.00 USD
Regular price
Sale price
$200.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Human Receptor Tyrosine-Protein Kinase ERBB-3/HER3 (C-FC), a cutting-edge product designed to revolutionize the field of molecular biology. This meticulously engineered protein offers unparalleled potential for advanced research and therapeutic applications.
The Recombinant Human Receptor Tyrosine-Protein Kinase ERBB-3/HER3 (C-FC) is a recombinant form of the ERBB-3/HER3 receptor, a crucial component of the ERBB family of receptor tyrosine kinases. This protein is produced through a meticulous process of genetic recombination, ensuring its utmost purity and functionality.
With its exceptional specificity and affinity for ligand binding, the Recombinant Human Receptor Tyrosine-Protein Kinase ERBB-3/HER3 (C-FC) serves as an invaluable tool for elucidating the intricate signaling pathways associated with ERBB-3/HER3 activation. Researchers can now delve into the molecular mechanisms underlying various physiological and pathological processes, including cell proliferation, differentiation, and survival.
Moreover, this product's remarkable potential extends beyond basic research. The Recombinant Human Receptor Tyrosine-Protein Kinase ERBB-3/HER3 (C-FC) holds immense promise as a therapeutic target for various diseases, particularly cancer. Its aberrant activation has been implicated in numerous malignancies, making it an attractive candidate for targeted therapies. By utilizing this recombinant protein, scientists can develop novel therapeutic strategies aimed at inhibiting ERBB-3/HER3 signaling, thereby impeding tumor growth and progression.
The Recombinant Human Receptor Tyrosine-Protein Kinase ERBB-3/HER3 (C-FC) is meticulously manufactured under stringent quality control measures, ensuring its utmost purity, stability, and bioactivity. Each batch undergoes rigorous testing to guarantee its conformity to the highest industry standards.
In conclusion, the Recombinant Human Receptor Tyrosine-Protein Kinase ERBB-3/HER3 (C-FC) represents a groundbreaking advancement in the realm of molecular biology. Its unrivaled specificity, affinity, and potential for therapeutic intervention make it an indispensable tool for researchers and clinicians alike. Embrace the future of scientific exploration and medical innovation with this exceptional product.
The Recombinant Human Receptor Tyrosine-Protein Kinase ERBB-3/HER3 (C-FC) is a recombinant form of the ERBB-3/HER3 receptor, a crucial component of the ERBB family of receptor tyrosine kinases. This protein is produced through a meticulous process of genetic recombination, ensuring its utmost purity and functionality.
With its exceptional specificity and affinity for ligand binding, the Recombinant Human Receptor Tyrosine-Protein Kinase ERBB-3/HER3 (C-FC) serves as an invaluable tool for elucidating the intricate signaling pathways associated with ERBB-3/HER3 activation. Researchers can now delve into the molecular mechanisms underlying various physiological and pathological processes, including cell proliferation, differentiation, and survival.
Moreover, this product's remarkable potential extends beyond basic research. The Recombinant Human Receptor Tyrosine-Protein Kinase ERBB-3/HER3 (C-FC) holds immense promise as a therapeutic target for various diseases, particularly cancer. Its aberrant activation has been implicated in numerous malignancies, making it an attractive candidate for targeted therapies. By utilizing this recombinant protein, scientists can develop novel therapeutic strategies aimed at inhibiting ERBB-3/HER3 signaling, thereby impeding tumor growth and progression.
The Recombinant Human Receptor Tyrosine-Protein Kinase ERBB-3/HER3 (C-FC) is meticulously manufactured under stringent quality control measures, ensuring its utmost purity, stability, and bioactivity. Each batch undergoes rigorous testing to guarantee its conformity to the highest industry standards.
In conclusion, the Recombinant Human Receptor Tyrosine-Protein Kinase ERBB-3/HER3 (C-FC) represents a groundbreaking advancement in the realm of molecular biology. Its unrivaled specificity, affinity, and potential for therapeutic intervention make it an indispensable tool for researchers and clinicians alike. Embrace the future of scientific exploration and medical innovation with this exceptional product.
Share
